Mednet Logo

How do you approach treatment of a subtotally resected low grade glioma in a young patient?

Do molecular factors (1p/19q, IDH status) influence your choice of dose/volumes?
Community PollStarted

In a young patient with a subtotally resected 1p/19q co-deleted low grade glioma, would you recommend:

286 physicians have voted

Join Mednetto vote and see how they answered.

5 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Florida International University
Answered on

The management philosophy for LGG is radically shifting. For years, the belief was that these were essentially "incurable", slow-growing tumors, and hence the original debate centered around observation versus resection; the observation camp is now squarely in the minority. The debate then shifted t...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine
Answered on · Updated on

Given RTOG9802 showed OS benefit for RT/chemotherapy vs RT alone, which also included those with age <40 and STR, I would favor adjuvant RT AND chemotherapy (Buckner et al, NEJM 2016). Furthermore, there is this new diagnostic criteria based on CIMPACT-NOW consensus that low grade IDH-wildtype astro...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Yale Cancer Center At Smilow Cancer Hospital
Answered on

Excellent discussion below. Given that the early vs. delayed XRT shows improvement in seizure-free survival, I think that earlier XRT is particularly beneficial for patients with seizures or large unresected or partially lesions that are already symptomatic. In my experience these large lesions are ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Colorado School of Medicine
Answered on

In a young patient with a subtotally resected low grade glioma, I give the options of radiation therapy now vs at the time of symptomatic or imaging progression. In general, I favour delayed radiation therapy given the results of the European study that showed no change in survival outcomes. At the ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · University of Missouri at Columbia, Ellis Fischel Cancer Cener
Answered on

As stated above 9802 RT+PCV demonstrated survival advantage over RT alone which took years to see the OS benefit, implying a durable benefit to upfront treatment. So any high risk feature low grade glioma should be considered for adjuvant RT.

In terms of molecular factors, several excellent articles...

Join for free or sign in to see the full answer